You are here: All Products  > Jacobio to Start Phase III Trial of Novel Combination in NSCLC with KRAS G12C Mutations

Jacobio to Start Phase III Trial of Novel Combination in NSCLC with KRAS G12C Mutations

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products